News
Shares of Charles River Laboratories International Inc. CRL rallied 2.92% to $158.39 Tuesday, on what proved to be an ...
1d
Zacks Investment Research on MSNReasons to Retain Charles River Stock in Your Portfolio for NowCRA International, Inc. CRAI, or Charles River Associates, has had an impressive run over the past month. Its shares have ...
This was the stock's second consecutive day of losses.
CBS Boston on MSN2d
What to know about Boston's Charles River Jazz FestivalThe Charles River Jazz Festival happening next week in Boston. Here's what to know. Bands Continue Exiting Radar Festival ...
FDA's plan to phase out animal testing may hurt Charles River's revenues. The DCF model suggests that CRL presents an ...
Summertime and the livin’s easy. But you don’t have to spend a fortune to enjoy all the city has to offer. There are plenty ...
The Charles River, despite past improvements, has stalled in its progress toward becoming consistently swimmable. Polluted ...
Charles River Laboratories International, Inc. is an early-stage contract research company, which provides essential products and services to help pharmaceutical ...
Charles River is by far the leader in pre-clinical development, with each segment of its business occupying 35% to upward of 40% market share, which is generally twice the size of the No. 2 player.
Charles River is by far the leader in pre-clinical development, with each segment of its business occupying 35% to upward of 40% market share, which is generally twice the size of the No. 2 player.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results